Business
Director/PDMR dealing and grant of options
Director/PDMR dealing and grant of options.

About this update from Ebiquity Plc
[{"type":"text","content":"\n \nRNS Number : 7628E Ebiquity PLC 13 February 2018 \n\nEbiquity plc \n('Ebiquity' or the 'Company')\n \nDirector/PDMR dealing and grant of options\n \n13th February 2018\n \nEbiquity has today awarded options over ordinary shares of 25 pence each in the share capital of the Company (\"Ordinary Shares\") to certain directors and PDMR's as detailed below. These relate to the period which commenced on 1st January 2016 and the period which commenced on 1st January 2017. Each option over an Ordinary Share has an exercise price of 25 pence. \n \nThe options will vest conditional on the satisfaction of performance criteria relating to the compound growth of the Company's diluted adjusted earnings per share (\"EPS\") over a five-year period, in accordance with the following: -\n \n· EPS growth of 10% over the relevant performance period will vest the option in full\n· EPS growth of 4% over the relevant performance period will vest one fifth of the grant\n· None will vest if EPS growth over the relevant performance period is less than 4%\n· Three-fifths will vest if EPS growth over the relevant performance period is 8%\n· The share option will vest on a straight-line basis where EPS growth over the relevant performance period is between 4% and 8% or between 8% and 10%\n \nOne quarter of each award will vest at the earlier date of the 30th April following the initial three-year period if the total shareholder returns (TSR) of the Company are in the top quartile of the TSR of the AIM Media Index over the same period. TSR is measured on the average share price of the Company in the 20 trading days immediately following the preliminary announcement of results for the third financial year relative to the 20 trading days prior to 30th April of the first year. If this condition is not met, the total award will be capable of vesting according to EPS growth over the five-year period.\n \nThe individual grants are as follows: -\n \n\n\n\n\nRecipient\n\n\nJob Title\n\n\nNumber of shares subject to option\n\n\nVesting Date\n\n\n\n\nMichael Karg\n\n\nChief Executive Officer\n\n\n350,000\n\n\n30th April 2021\n\n\n\n\nAndy Noble\n\n\nChief Finan...